Purchase Order 75H71024P00328
- Not listed
- The Indian Health Service awarded a purchase order to Roche Diagnostics Corporation for laboratory supplies valued at $22,632.11 under a firm fixed-price contract. This order, issued on January 14, 2026, represents a child action under the parent indefinite delivery contract 75H70519D00022, with performance extending through January 31, 2026. The supplies were invoiced by Roche Lab Supplies for the period September 1 through October 6, 2022, and will be delivered to the Cass Lake, Minnesota...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at up to $80,000.00, is a firm fixed-price purchase order from the Indian Health Service (IHS), a component of the U.S. Department of Health and Human Services, for supplies including reagents, test kits, and consumables for the IHS laboratory department on an as-needed basis. The...
- Roche Diagnostics Corporation was awarded a delivery order valued at $25,550.49 by the Indian Health Service on December 13, 2024, for the period of January 1 through March 31, 2025. This firm fixed-price contract, awarded without a set-aside designation, represents a task order under the WEHC (likely a larger contract vehicle) and will be performed in Ogema, Minnesota. As a leading global manufacturer of in vitro diagnostic solutions, Roche Diagnostics supplies laboratory equipment, testing...
- Roche Diagnostics Corporation received a $5.01 million firm fixed-price delivery order from the Indian Health Service on March 29, 2022, for CPT chemistry analyzer equipment, reagents, supplies, and consumables to support the GIMC Laboratory Department through March 31, 2027. This contract is a modification (Mod 6) exercising Option 4 under a parent General Services Administration Schedule contract for Critical Analyzers, Laboratory (FSS-66-III), and was awarded without set-aside designation...
- The Indian Health Service awarded a $58.8K delivery order to Roche Diagnostics Corporation for laboratory equipment and diagnostic services at the Tohatchi, New Mexico facility. This firm fixed-price contract, effective April 1, 2020 through March 31, 2021 with ultimate closure on June 30, 2021, was awarded without set-aside designation on March 18, 2020. The delivery order is a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule, which...
- Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Indian Health Service, with a potential value of $41,224.32. The contract has no set-aside designation and runs from June 6, 2019 through February 28, 2024 to provide laboratory supplies for the FY18 Gallup, New Mexico GIMC Laboratory. Roche Diagnostics Corp will deliver critical medical equipment, reagents, test kits and associated consumables to support clinical chemistry,...
- This contract, awarded by the Indian Health Service (IHS) to Roche Diagnostics Corporation, is for the delivery of cost-per-test analyzers and preventative maintenance services. The contract has a ceiling value of $373,768.67 and a period of performance ending on March 31, 2025. The contract type is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment,...
- The Department of Health and Human Services Indian Health Service awarded a $150,000 firm fixed price purchase order to Roche Diagnostics Corporation. The contract is for Roche to provide 23-GIMC Laboratory Service Vendor services to the Castleton, Indiana facility from September 2023 through March 2024. As part of IHS's efforts to support healthcare services for Native American communities, this contract will facilitate clinical laboratory testing for patients through a period of performance...
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The $4,247.84 contract is for Roche's Accu-Check Inform II point-of-care testing devices and associated supplies for the Ak-Chin Clinic laboratory department. The award has an ultimate completion date of October 31, 2025 and was not set aside for any socioeconomic...
- Roche Diagnostics Corporation was awarded a delivery order valued at $345,478.67 for an instrumentation system with histology staining technology capabilities to support the Phoenix Area Indian Health Service (PAIHS). The contract, awarded on June 24, 2019, operates under firm fixed price terms with an ultimate completion date of July 31, 2025. This delivery order is a child contract under the Scientific Equipment and Services General Services Administration Schedule (FSS-66) and was funded...
The Indian Health Service awarded a $75,681.84 firm fixed-price purchase order to Roche Diagnostics Corporation on January 4, 2024, for a five-year instrument placement agreement that includes reagent and quality control test kits procurement. The contract, which serves the IHS laboratory department facility in Chinle, Arizona, has an ultimate completion date of September 30, 2025, and was awarded without set-aside designation. As a global leader in in vitro diagnostics and laboratory instrumentation, Roche Diagnostics Corporation provides comprehensive diagnostic solutions including molecular analyzers, reagents, and associated testing supplies to federal healthcare agencies, positioning this agreement within the company's broader portfolio of healthcare technology support across federal medical systems. This purchase order represents a child contract under Roche's established federal contracting relationships and reflects the company's sustained presence as a primary supplier of advanced diagnostic capabilities to civilian federal healthcare agencies. The agreement aligns with IHS's operational requirements to support laboratory testing capabilities at its clinical facilities, leveraging Roche's extensive experience delivering diagnostic instruments and consumables to federal healthcare networks. The contract closure and associated deobligation activities scheduled through September 2025 indicate standard completion procedures for this procurement vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Close Out | ($103k) | 1/14/26 | |
| P00008 | Supplemental Agreement for work within scope | $0 | 8/31/25 | |
| P00007 | Supplemental Agreement for work within scope | $0 | 7/31/25 | |
| P00006 | Exercise an Option | $0 | 6/25/25 | |
| P00005 | Exercise an Option | $60.0k | 4/28/25 |